具有肿瘤多药耐药逆转作用的金雀异黄素衍生物的合成及生物活性研究

细胞膜P-糖蛋白(P-gp)介导的药物外流是肿瘤多药耐药(MDR)产生的重要机制,异黄酮类化合物可以通过抑制P-gp活性发挥MDR逆转作用.通过对P-gp抑制剂进行结构分析,以金雀异黄素为母体,在其7位、8位及4'位分别引进碱性边链,设计、合成了20个金雀异黄素衍生物(其中16个未见文献报道),并检测了其多药耐药逆转活性.结果表明,大多数目标化合物对人白血病耐药细胞株K562/A02具有不同程度的耐药逆转作用.其中目标化合物8a,8b,8d,8e逆转作用较强,逆转倍数分别为8.97,6.36,5.19和5.82.     

柴胡逆转肝细胞癌多药耐药作用与相关机制的研究

选用对VCR天然耐药肝癌细胞株Bel-7402为对象来研究柴胡逆转MDR效果与相关的机制,以寻找一种新型的具有多药耐药逆转活性的中药.结果表明,柴胡具有逆转肝细胞癌多药耐药作用,并与抗癌药物VCR有协同作用.柴胡对人肝癌Bel-7402细胞株具有多药耐药逆转作用,提高了耐药细胞内的VCR含量,增加了VCR对细胞G2期阻滞作用,抑制了P-170糖蛋白的表达,抑制MDR1/mRNA的表达,提高了TopoαmRNA水平.     

基于报告基因技术的MDR1转录抑制剂高通量筛选模型的建立和应用

MDR1基因是引起肿瘤多药耐药的主要基因,其编码的P-gp蛋白可持续将药物由胞内排出胞外以降低胞内药物浓度导致多药耐药,MDR1基因的转录抑制剂可抑制MDR1基因在癌细胞中的表达,从而逆转肿瘤多药耐药.通过克隆MDR1基因的启动子,将其插入pGL3-basic质粒构建MDR1-luc＋报告基因载体,再将重组载体转染入HepG2肝癌细胞并筛选单克隆细胞株,构建了MDR1启动子的高通量筛选模型,Z′因子为0.75;通过对中药样品库的筛选,得到两种中药提取物高良姜水提物、红豆蔻醇提物有明显耐药逆转效果,EC50值分别为高良姜水提物16.37mgL-1和红豆蔻醇提物14.96mgL-1,RT-PCR验证上述两种阳性样品具有明显的抑制MDR1基因表达的作用.以上结果为MDR1基因的转录抑制剂高通量筛选奠定了基础.     

基于纳米银/多壁碳纳米管修饰电极的电化学法测定磺胺甲唑

以表面处理多壁碳纳米管(MWCNTs)和硝酸银为原料,利用硼氢化钠还原法制备了纳米银/多壁碳纳米管复合材料(AgNPs/MWCNTs),并通过紫外-可见吸收光谱、红外光谱、拉曼光谱和X射线衍射进行表征。采用滴涂法将该纳米复合材料修饰至玻碳电极表面,得到纳米银/多壁碳纳米管修饰电极(AgNPs/MWCNTs/GCE)。以AgNPs/MWCNTs/GCE为工作电极,研究了缓冲溶液、pH值、支持电解质和扫描速度对磺胺甲■唑(SMZ)电化学反应活性的影响。结果表明,与多壁碳纳米管、纳米银单独修饰电极相比,该纳米复合材料修饰电极对SMZ显示了更高的电催化活性。优化条件下,SMZ浓度在3.0×10~(-7)～5.0×10~(-5) mol/L范围内与峰电流呈线性关系,检出限(S/N=3)为6.4×10~(-8) mol/L。该方法操作简单、快速,可用于河水样品中SMZ的检测。     

抗耐药性病原菌感染以及具有多药耐药逆转活性的天然产物研究进展

综述了近年来抗耐药性病原菌感染和具有多药耐药逆转活性的天然产物的研究进展,重点介绍了这类天然产物的结构特征、生理活性和部分化合物的全合成研究.     

一些全氟(及多氟)有机化合物蒸汽压的QSPR研究

全氟(及多氟)化合物(PFCs)是环境中普遍存在的新一类持久性有机污染物。对其中有蒸汽压数据的35个全氟(及多氟)化合物进行了HF/6-31G*水平上的结构优化,并在优化结构的基础上进行分子表面静电势及其导出参数的计算。分别用"留一法"交叉验证及外部测试集对模型进行检验。结果表明,分子表面静电势参数结合分子表面积可以很好地表达全氟(及多氟)化合物与其分子结构间的定量关系,所建立的QSPR模型具有较强的稳健性和预测能力,同时也证明了分子静电势在全氟化合物QSPR研究中的适用性。     

聚合物对多壁碳纳米管的包覆改性研究

探讨了聚合物对碳纳米管的包覆改性.将多壁碳纳米管(MWNTs)通过浓硫酸和浓硝酸的混酸(体积比=3∶1)处理,使其带上羧基.将羧化MWNTs与甲基丙烯酸缩水甘油酯(GMA),苯乙烯双组分接枝聚苯乙烯(PS-g-(GMA-co-St))通过溶液共混方法,使其接在MWNTs上的羧基和GMA所带的环氧基团之间发生酯化反应,实现MWNTs表面接枝上PS-g-(GMA-co-St).扫描电镜观察表明,羧化MWNTs平均管径约为40nm,而接枝上PS-g-(GMA-co-St)的改性MWNTs管径可达约100nm.用四氢呋喃(THF)对表层包覆的PS-g-(GMA-co-St)刻蚀后,其直径降回到约40nm,这和先前观察到的羧化MWNTs的直径基本一致.对刻蚀后的MWNTs样品的FT-IR分析也表明MWNTs表面上存在接枝PS.表面经过PS-g-(GMA-co-St)修饰后,可以形成包覆层,为MWNTs在聚合物基体中分散、制备纳米功能材料提供了途径.     

多溴代二苯胺热力学性质的密度泛函理论研究

在B3LYP/6-31G*水平上对209个多溴代二苯胺(PBDPA)系列化合物进行了全优化和振动分析计算, 得到各分子在298.15 K, 101.3 kPa标准状态下的热力学参数. 设计等键反应, 计算了PBDPA系列化合物的标准生成热(ΔfHÖ)和标准生成自由能(ΔfGÖ). 研究了热力学参数SÖ与溴原子的取代位置及取代数目(NPBS)之间的关系, 结果表明: PBDPA系列化合物的SÖ, ΔfHÖ和ΔfGÖ与NPBS之间有很强的相关性(R2≥0.984). 根据异构体标准生成自由能的相对大小, 从理论上求得异构体的相对稳定性. 以Gaussian 03程序的输出文件为基础, 采用统计热力学程序计算了PBDPA化合物在200 K至1000 K的摩尔恒压热容(Cp,m), 并用最小二乘法求得Cp,m与温度之间的相关方程, 发现Cp,m与T, T－1和T－2之间有着很好的相关性(R2＝1.000).     

单分子力谱研究活细胞上多药耐药相关蛋白1的表达

采用原子力显微镜的单分子力谱(SMFM)技术研究了多药耐药相关蛋白1(MRP1)与其抗体间的相互作用, 并考察了人舌癌细胞系TCA8113经高剂量平阳霉素(BLM)反复间歇诱导前后细胞表面MRP1的表达差异. 实验结果表明, MRP1与其抗体之间存在特异性相互作用力, 当针尖运动速率为2.5 μm/s时, 作用力大小约为(182±35) pN; 而且药物诱导后MRP1在人舌癌细胞上的表达明显增强. 本工作为了解活细胞水平上MRP1的表达提供了新方法, 有助于肿瘤细胞多药耐药性(MDR)的研究.     

硼酸与多羟基化合物配位反应的热化学研究

用量热法在298.2 K测定了B(OH)~-_4与多羟基化合物的反应焓。计算了硼酸与多羟基化合物的配位焓和配离子的标准生成焓。根据配位焓确定了B(OH)~-_4与甘露醇、山梨醇、丙三醇、葡萄糖等多羟基化合物配位反应的配位数，B(OH)~-_4与甘露醇、山梨醇的配位数是2；与丙三醇、葡萄糖的配位数是1．     

FG020326 sensitized multidrug resistant cancer cells to docetaxel-mediated apoptosis via enhancement of caspases activation

Apoptotic resistance is the main obstacle for treating cancer patients with chemotherapeutic drugs. Multidrug resistance (MDR) is often characterized by the expression of P-glycoprotein (P-gp), a 170-KD ATP-dependent drug efflux protein. Functional P-gp can confer resistance to activate caspase-8 and -3 dependent apoptosis induced by a range of different stimuli, including tumor necrosis and chemotherapeutic drugs such as docetaxel and vincristine. We demonstrated here that comparison of sensitive KB cells, P-gp positive (P-gp(+ve)) KBv200 cells were extremely resistant to apoptosis induced by docetaxel. FG020326, a pharmacological inhibitor of P-gp function, could enhance concentration-dependently the effect of docetaxel on cell apoptosis and sensitize caspase-8, -9 and -3 activation in P-gp overexpressing KBv200 cells, but not in KB cells. Therefore, the enhancement of caspase-8, -9 and -3 activation induced by docetaxel may be one of the key mechanisms of the reversal of P-gp mediated docetaxel resistance by FG020326.     

In silico analysis of a few dietary phytochemicals as potential tumor chemo-sensitizers

P-glycoprotein (P-gp) is a membrane ATP-binding cassette (ABC) transporter that extrudes different xenobiotics out of cells. Besides its tissue protection role, overexpression of P-gp on the surface of many neoplastic cells restricts the cell entry of many anti-cancer drugs, the phenomenon which is known as multidrug resistance (MDR). It has been demonstrated that MDR cells can be sensitized toward anti-cancer agents when treated with P-gp inhibitors/modulators known as chemo-sensitizers. Due to the clinical significance and also considering the fact that many P-gp inhibitors are transported by P-gp, the search for more potent and low toxic non-transported chemo-sensitizers is an active area of research. Regarding this, several naturally occurring compounds were reported as MDR reversal agents, a category which is generally referred to as “fourth-generation P-gp inhibitors.” Dietary supplements containing natural products are widely used, and it is possible that they interact with co-administered pharmaceutical substances that are P-gp substrates, leading to altered pharmacokinetic profile. In silico approaches for quantitative and quantitative prediction of binding mechanism of dietary natural products to P-gp may be regarded as appropriate strategy in the early phase of drug discovery projects since they describe structural features of various phytochemicals for interaction with P-gp and pave the way toward alternative and novel anti-MDR scaffolds. In the present contribution, some phytochemicals of turmeric, black pepper, and green tea as commonly consumed dietary sources were subjected to systematic combined in silico analysis including molecular docking and amino acid decomposition analysis through B3LYP functional in association with 6-31G basis set. On the basis of major identified drug binding sites within P-gp internal pocket, modeled natural compounds were categorized as substrate, inhibitor, or modulator while structure binding relationship of each category was developed and elucidated.     

新型紫杉烷类衍生物的制备及生物活性评价

多药耐药性问题是导致第一代紫杉烷药物在临床化疗失败的主要原因。本文对紫杉醇C7、C10、C14、C3′多个位点的取代基进行改造,针对合成的6个新型的紫杉烷化合物,在体外考察其对多药耐药肿瘤细胞株以及人结肠癌HCT-116干细胞的增殖抑制活性,实验结果表明6个化合物的抗多药耐药活性均优于紫杉醇。采用P-gp高表达的犬肾细胞MDCK-MDR1进一步研究高活性候选化合物JT-3与P-gp的相互作用。以此研发抗多药耐药型的新一代紫杉烷类药物,对开发扩大抗癌新适应症的新一代紫杉烷类抗癌药意义重大。     

Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment

Multidrug resistance (MDR) remains a major problem in cancer therapy and is characterized by the overexpression of p-glycoprotein (P-gp) efflux pump, upregulation of anti-apoptotic proteins or downregulation of pro-apoptotic proteins. In this study, an Apolipoprotein A1 (ApoA1)-modified cationic liposome containing a synthetic cationic lipid and cholesterol was developed for the delivery of a small-molecule chemotherapeutic drug, doxorubicin (Dox) to treat MDR tumor. The liposome-modified by ApoA1 was found to promote drug uptake and elicit better therapeutic effects than free Dox and liposome in MCF-7/ADR cells. Further, loading Dox into the present ApoA1-liposome systems enabled a burst release at the tumor location, resulting in enhanced anti-tumor effects and reduced off-target effects. More importantly, ApoA1-lip/Dox caused fewer adverse effects on cardiac function and other organs in 4T1 subcutaneous xenograft models. These features indicate that the designed liposomes represent a promising strategy for the reversal of MDR in cancer treatment.     

A new taxoid from a callus culture of Taxus cuspidata as an MDR reversal agent

A new taxoid, 5alpha,13alpha-diacetoxy-10beta-cinnamoyloxy-4(20),11-taxadien-9alpha-ol (1) along with its 9,10-isomer, taxinine NN-11 (2) were isolated from the callus cultures of Taxus cuspidata. The structures were identified by the analyses of the spectral data and chemical method. Their in vitro cytotoxicity against 3 cell lines (HepG2, WI-38 and VA-13) and multidrug resistance (MDR) reversal activity toward 2780AD tumor cells were preliminarily evaluated, the low cytotoxicities and potent MDR reversal activities suggested that they might be good lead compounds of tumor MDR reversal agent.     

Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance

Multidrug resistance (MDR) is regarded as a main obstacle for effective chemotherapy, and P-glycoprotein (P-gp)-mediated drug efflux has been demonstrated to be the key factor responsible for MDR. In this study, a novel pH-responsive hybrid drug delivery system was developed by conjugating d -α-tocopheryl polyethylene glycol 1000 succinate (TPGS), a kind of P-gp inhibitor, on the surface of laponite nanodisks to overcome MDR. The prepared LM-TPGS display excellent colloidal stability, a high encapsulation efficiency of doxorubicin (DOX), and a pH-responsive drug release profile. In vitro experiments verified that LM-TPGS/DOX could exhibit significantly enhanced therapeutic efficacy in treating DOX-resistant breast cancer cells (MCF-7/ADR) through inhibiting the activity of P-gp-mediated drug efflux and effectively accumulating DOX within cancer cells. In vivo results revealed that LM-TPGS/DOX outstandingly suppressed MCF-7/ADR tumors with low side effects. Therefore, the high drug payload, enhanced inhibition efficacy to drug-resistant cells, and low side effects make the LM-TPGS/DOX a promising nanoplatform to reverse MDR for effective chemotherapy.     

Total synthesis of agosterol A: an MDR-modulator from a marine sponge

The first total synthesis of agosterol A, a modulator of multidrug resistance (MDR) mediated by P-gp and MRP1, and isolated from a marine sponge, was achieved from ergosterol by utilizing a regioselective epoxy-cleavage reaction and regioselective dehydroxylation as the key reactions.